In-vitro diagnostic substances manufacturing · New York

Ortho Clinical Diagnostics - Building 313

Rochester, NY · ~610 workers · 2 years of OSHA Injury Tracking Application data.

B
Good Safety Record
2.4
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Ortho Clinical Diagnostics - Building 313 runs at 73% of its industry's injury rate - safer than the typical In-vitro diagnostic substances manufacturing workplace, earning a grade B.

Ortho Clinical Diagnostics - Building 313: 2.4 TCR = 73% of In-vitro diagnostic substances manufacturing BLS 3.3 · 2y Form 300A (see methodology below)

Ortho Clinical Diagnostics - Building 313 safety composite

Ortho Clinical Diagnostics - Building 313 scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on dart rate (safer than 16%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

F

28/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 2.41 per 100 workers

Safer than 24% of industry peers

DART rate
F 2.4 per 100 workers

Safer than 16% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

Ortho Clinical Diagnostics - Building 313: 1.4 → 3.4 TCR

Peak year 2018 @ 3.4 TCR · DART/TCR 1× in 2018

Ortho Clinical Diagnostics - Building 313's TCR rose 2.0 from 1.4 in 2017 to 3.4 in 2018. In 2018, DART was 1× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325413 · Rochester, NY AT/BELOW-IND · MID

Grade B · TCR 2.4 · 73% of ind

  • DART 2.4 DART
  • RANK #13/14
  • PHOTO Maine Biotechnology …
  • BOOK 2y book
  • INJ 26 inj
  • SIZE ~610 FTE

Nearest TCR peer: Maine Biotechnology Services (0.0 TCR gap)

Read with this employer → · Industry book → · New York employers → · Look up another →

Ortho Clinical Diagnostics - Building 313 in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Ortho Clinical Diagnostics - Building 313 averages 2.4 TCR (73% of the In-vitro diagnostic substances manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Ortho Clinical Diagnostics - Building 313 TCR series: 2017=1.4 · 2018=3.4 · BLS 3.3

Where Ortho Clinical Diagnostics - Building 313 falls in its industry

201 In-vitro diagnostic substances establishments

Safer than 24% of graded establishments in this industry, whose median TCR is 1.4.

More dangerous than peersSafer than peers

Narrower to New York alone (the establishments it most directly competes with for workers and contracts): ranked #13 safest of 14 In-vitro diagnostic substances employers in New York.

Ortho Clinical Diagnostics - Building 313 (610 employees, TCR 2.4) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 02,0004,0006,000 01234 Average employees Total Case Rate Ortho Clinical Diagnostics - Building 313
Ortho Clinical Diagnostics - Building 313 (610 employees, TCR 2.4) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4

Ortho Clinical Diagnostics - Building 313 has more employees than the In-vitro diagnostic substances manufactu median and a higher injury rate than the industry's median TCR of 1.4. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2018 3.4 2.4 19 1 0
2017 1.4 0.9 7 1 0

OSHA ITA peer cross-reference

Establishment peer ledger

325413 · NY · Rochester

201 In-vitro diagnostic substances manufacturing employers nationwide with a credible TCR · 21,008 rated employers in New York with headcount on file · 956 employers in Rochester, NY · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Maine Biotechnology Services 2.4 TCR
NAICS-TCR MarDx Diagnostics 2.4 TCR
NAICS-TCR Alere 2.4 TCR
NAICS-TCR Biomed Diagnostics, Inc. 2.5 TCR
STATE-SIZE Building Service 32BJ Benefit Funds 610 FTE
STATE-SIZE The Gleason Works 609 FTE
STATE-SIZE Ace Endico Corporation Brewster 611 FTE
STATE-SIZE Perinton 609 FTE
CITY-NEAR Division 50 University of Rochester 13,244 FTE
CITY-NEAR Rochester General Hospital 7,833 FTE
CITY-NEAR Division 40 University of Rochester 4,884 FTE
CITY-NEAR Unity Hospital 3,158 FTE
NAT-TCR Florida CPC 2.4 TCR
NAT-TCR Liberty Carton - Texas 2.4 TCR
NAT-TCR 4818-48180055-6290 Shelby View Dr.-Wc 2.4 TCR
NAT-TCR ROG 2.4 TCR
NAT-SIZE Kimball Electronics Jasper 610 FTE
NAT-SIZE WVUH Operations Support Center 610 FTE
NAT-SIZE Alorica Business Solutions LLC- Niles 610 FTE
NAT-SIZE Amzl : Dph1 610 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2018, 2017. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.